肾脏替代治疗创新方法技术路线图:变革的催化剂
自透析引入约70年来创新有限,肾脏健康倡议召集多学科组制定技术路线图,明确替代肾脏功能的设计标准及科学、技术、监管和支付里程碑,以推动颠覆性创新。
要点
- 路线图由多学科组制定,明确替代肾脏功能的设计标准及商业化里程碑。
- 路线图不预设特定方案,识别血管通路、生物材料、免疫调节等系统使能因素。
核心结论
- 需要 disruptive innovation 来改善肾脏替代治疗,技术路线图为此提供行动框架。
研究设计与样本
- 由肾脏健康倡议(美国肾脏病学会与FDA公私合作)召集多学科组制定技术路线图。
主要发现
- 自透析引入约70年来,透析或替代疗法创新很少。
- 路线图识别设计标准及科学、技术、监管和支付里程碑,并列出系统使能因素。
关键数值与推荐
- 路线图提供替代特定肾脏功能的估计时间线。
- 路线图已用于指导KidneyX创新奖的遴选。
临床怎么用
- 临床可参考路线图理解未来肾脏替代治疗的发展方向和评估框架。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The number of patients dialyzed for ESKD exceeds 500,000 in the United States and more than 2.6 million people worldwide, with the expectation that the worldwide number will double by 2030. The human cost of health and societal financial cost of ESKD is substantial. Dialytic therapy is associated with an unacceptably high morbidity and mortality rate and poor quality of life. Although innovation in many areas of science has been transformative, there has been little innovation in dialysis or alternatives for kidney replacement therapy (KRT) since its introduction approximately 70 years ago. Advances in kidney biology, stem cells and kidney cell differentiation protocols, biomaterials, sensors, nano/microtechnology, sorbents and engineering, and interdisciplinary approaches and collaborations can lead to disruptive innovation. The Kidney Health Initiative, a public-private partnership between the American Society of Nephrology and the US Food and Drug Administration, has convened a multidisciplinary group to create a technology roadmap for innovative approaches to KRT to address patients' needs. The Roadmap is a living document. It identifies the design criteria that must be considered to replace the myriad functions of the kidney, as well as scientific, technical, regulatory, and payor milestones required to commercialize and provide patient access to KRT alternatives. Various embodiments of potential solutions are discussed, but the Roadmap is agnostic to any particular solution set. System enablers are identified, including vascular access, biomaterial development, biologic and immunologic modulation, function, and safety monitoring. Important Roadmap supporting activities include regulatory alignment and innovative financial incentives and payment pathways. The Roadmap provides estimated timelines for replacement of specific kidney functions so that approaches can be conceptualized in ways that are actionable and attract talented innovators from multiple disciplines. The Roadmap has been used to guide the selection of KidneyX prizes for innovation in KRT.
引用
- Bonventre JV, Hurst FP, West M, et al. A Technology Roadmap for Innovative Approaches to Kidney Replacement Therapies: A Catalyst for Change. Clin J Am Soc Nephrol. 2019. PMID: 31562182. doi:10.2215/CJN.02570319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。